(Q40098920)
Statements
Downregulation of retinoblastoma protein is involved in the enhanced cytotoxicity of 4-hydroxytamoxifen plus mifepristone combination therapy versus antiestrogen monotherapy of human breast cancer (English)
Patricia V Schoenlein
Min Hou
Julia S Samaddar
Virgil T Gaddy
Muthusamy Thangaraju
Jill Lewis
Maribeth Johnson
Andre Kallab
John T Barrett
Vadivel Ganapathy